Yue Cao

Yue Cao

Auto-generated profile, based on publicly available information

Yue Cao

Tianjin Key Laboratory of Animal and Plant Resistance, College of Life Sciences, Tianjin Normal University, 393 West Binshui Road, Xiqing District, Tianjin, 300387, China

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
YCYue Cao
Yue Cao
XGXiaokun Gang
Xiaokun Gang
CSChenglin Sun
Chenglin Sun
GWGuixia Wang
Guixia Wang
Mesenchymal stem cells (MSCs), an ideal cell source for regenerative therapy with no ethical issues, play an important role in diabetic foot ulcer (DFU). Growing evidence has demonstrated that MSCs transplantation can accelerate wound closure, ameliorate clinical parameters, and avoid amputation. In this review, we clarify the mechanism of preclinical studies, as well as safety and efficacy of clinical trials in the treatment of DFU. Bone marrow-derived mesenchymal stem cells (BM-MSCs), compared with MSCs derived from other tissues, may be a suitable cell type that can provide easy, effective, and cost-efficient transplantation to treat DFU and protect patients from amputation.

1 January 2016 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
YCYue Cao
Yue Cao
XJXinli Jiang
Xinli Jiang
HMHuijie Ma
Huijie Ma
YWYuling Wang
Yuling Wang
PXPeng Xue
Peng Xue
YLYan Liu
Yan Liu

15 October 2017 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
YCYue Cao
Yue Cao
ZYZi Yan
Zi Yan
TZTong Zhou
Tong Zhou
GWGuixia Wang
Guixia Wang
Type 2 diabetes mellitus is a complex age-related metabolic disease. Cognitive dysfunction and learning and memory deficits are main characteristics of age-related metabolic diseases in the central nervous system. The underlying mechanisms contributing to cognitive decline are complex, especially cognitive dysfunction associated with type 2 diabetes mellitus. SIRT1, as one of the modulators in insulin resistance, is indispensable for learning and memory. In the present study, deacetylation, oxidative stress, mitochondrial dysfunction, inflammation, microRNA, and tau phosphorylation are considered in the context of mechanism and significance of SIRT1 in learning and memory in diabetic and nondiabetic murine models. In addition, future research directions in this field are discussed, including therapeutic potential of its activator, resveratrol, and application of other compounds in cognitive improvement. Our findings suggest that SIRT1 might be a potential therapeutic target for the treatment of cognitive impairment induced by type 2 diabetes mellitus.

8 June 2016 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
XLXuyi Li
Xuyi Li
YLYan Liu
Yan Liu
HMHuijie Ma
Huijie Ma
YGYue Guan
Yue Guan
YCYue Cao
Yue Cao
YZYi Zhang
Yi Zhang
Background and Aims: Previous studies demonstrated that energy metabolism disturbance impairs cardiac function and chronic intermittent hypobaric hypoxia (CIHH) protects heart against ischemia/reperfusion injury. The present study aimed to test the hypothesis that CIHH protects the heart against ischemia/reperfusion (I/R) injury via improvement of cardiac glucose metabolism. Methods: Male Sprague-Dawley rats received CIHH treatment simulating 5000-meter altitude for 28 days,6 hours per day in a hypobaric chamber,or no treatment (control). Body weight, fasting blood glucose, blood lipid and glucose tolerance were measured. The left ventricular function of isolated hearts was evaluated during 30 minutes of ischemia and 60 minutes of reperfusion using Langendorff method. The mRNA and protein expression involved in cardiac energy metabolism was determined using quantitative PCR and Western blot techniques. Results: 1. There was no difference of body weight, fast blood glucose, blood lipid and glucose tolerance between control and CIHH rats under baseline condition (p>0.05). 2. The recovery of left ventricular function after I/R was improved significantly in CIHH rats compared to control rats (p<0.05). 3. The expression of cardiac GLUT4 and PGC-1α were increased but PDK4 gene expression was decreased by CIHH treatment at both mRNA and protein level. Also p-AMPK/AMPK ratio was increased in CIHH rats (p<0.05). Conclusion: CIHH ameliorated I/R injury through improving cardiac glucose metabolism via upregulation of GLUT4, p-AMPK and PGC-1α expressions, but downregulation of cardiacPDK4 expression.

19 March 2020 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
TZTong Zhou
Tong Zhou
LSLin Sun
Lin Sun
SYShuo Yang
Shuo Yang
YLYou Lv
You Lv
YCYue Cao
Yue Cao
GWGuixia Wang
Guixia Wang
20(S)-Ginsenoside Rg3 (20(S)-Rg3) has been shown to induce apoptosis by interfering with several signaling pathways. Furthermore, it has been reported to have anticancer and antidiabetic effects. In order to detect the protective effect of 20(S)-Rg3 on diabetic kidney disease (DKD), diabetic rat models which were established by administering high-sugar, high-fat diet combined with intraperitoneal injection of streptozotocin (STZ), and age-matched wild-type (WT) rat were given 20(S)-Rg3 for 12 weeks, with three groups: control group (normal adult rats with saline), diabetic group (diabetic rats with saline), and 20(S)-Rg3 treatment group (diabetic rats with 20(S)-Rg3 (10 mg/kg body weight/day)). The biochemical indicators and the changes in glomerular basement membrane and mesangial matrix were detected. TUNEL staining was used to detect glomerular and renal tubular cell apoptosis. Immunohistochemical staining was used to detect the expression of fibrosis factors and inflammation factors in rat kidney tissues. Through periodic acid-Schiff staining, we observed that the change in renal histology was improved and renal tubular epithelial cell apoptosis decreased significantly by treatment with 20(S)-Rg3. Plus, the urine protein decreased in the rats with the 20(S)-Rg3 treatment. Fasting blood glucose, creatinine, total cholesterol, and triglyceride levels in the 20(S)-Rg3 treatment group were all lower than those in the diabetic group. Mechanistically, 20(S)-Rg3 dramatically downregulated the expression of TGF-β1, NF-κB65, and TNF-α in the kidney. These resulted in a significant prevention of renal damage from the inflammation. The results of the current study suggest that 20(S)-Rg3 could potentially be used as a novel treatment against DKD.